drugset / Trial / NCT02274870
Liposomal Bupivacaine for Post Operative Pain After Knee Replacement Surgery
RandomizedParallel-groupOpen-labelTreatment
Summary
Continuous femoral nerve blocks (CFNB) provide effective pain control to patients undergoing total knee replacement (TKR). However the resulting motor blockade can lead to decreased quadriceps muscle strength and delayed functional recovery.The purpose of this study is to compare the effect of Liposome Bupivacaine infiltration into the knee to CFNB on pain control and functional recovery
Timeline
- Start
- 2014-11
- Primary completion
- 2016-12
- Completion
- 2017-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 150 mg | Other |
| Subject | Liposome bupivacaine | Unknown | 266 mg | Other |
Indications
No indication recorded.